Article: Hepatitis B infection poses fulminant hepatic failure risk in infants.

Article: Hepatitis B virus (HBV) genotypes in Egyptian ...
Virology Journal;  July 15, 2007 ;     700+ words ... ... of complications, hepatitis B e antigen (HBeAg ... response to treatment of HBV infection and possibly ... University suffering from hepatitis and were diagnosed as HBV infection. HBV was ... with chronic active hepatitis (CAH). HBV related acute forms ...

Article: Cytel's Theradigm-HBV successfully stimulates a ...
Business Wire;  March 14, 1996 ;     700+ words ... ... Theradigm(TM)-HBV, in a Phase II trial safely stimulated a hepatitis B-specific immune ... therapeutically relevant. Hepatitis B (HBV), a disease prevalent ... trials of Theradigm-HBV are being presented ... Industry Congress on Hepatitis in Washington, D ...

Article: Gilead starts Ph III program of HBV candidate.(Gilead ...
Pharma Marketletter;  July 25, 2005 ;     669 words ... ... disoproxil fumarate for the treatment of chronic hepatitis B. Two randomized, double-blind, Phase ... patients with either HBeAg-positive chronic HBV or anti-HBe positive chronic hepatitis HBV, over a 48-week period at more than 100 centers ...

Article: Immunization (HBV) WHO Finds No Scientific Justification ...
Hepatitis Weekly;  October 19, 1998 ;     684 words ... ... evidence on whether the hepatitis B virus (HBV) vaccine can cause ... chronic carrier state of hepatitis B. HBV vaccine is the first ... delay introduction of HBV vaccine. There are ... chronic carriers of hepatitis B at high risk from ...

Article: Hepsera reduces lamivudine-resistant HBV levels in liver ...
Transplant News;  February 16, 2004 ;     700+ words ... ... lamivudine-resistant chronic hepatitis B (HBV) infection, significantly ... lamivudine-resistant HBV who are at high risk ... Hepatology. Treatment with hepatitis B immune globulin and ... lamivudine ameliorate HBV recurrence, but emerging ...

Article: HBV genomic variability not seen to exacerbate chronic ...
Hepatitis Weekly;  April 26, 2004 ;     700+ words ... ... the basic core promoter of hepatitis B virus (HBV) genome, and genotype ... fulminant or subfulminant hepatitis. Genotyping of HBV was performed by polymerase ... exacerbation of chronic hepatitis B in Taiwanese HBV carriers." Liu and colleagues ...

Article: Achillion Pharmaceuticals Licenses Vion's Antiviral Agent for the ...
PR Newswire;  February 8, 2000 ;     700+ words ... ... inhibitor of the replication of HBV and demonstrated results superior ... FDA-approved treatments. HBV is a causative agent of both acute and chronic forms of hepatitis that affects about 300 million people worldwide. HBV also predisposes its victims ...